Dernick R
Dev Biol Stand. 1981;47:319-33.
The molecular basis for future developments of poliovirus vaccines is the detailed knowledge of the structure of the virion. Different types and forms of poliovirus particles are detected in virus preparations. Physical and chemical properties characterize the virion better than its electron microscopic image. The compact poliovirus particle is dissociated only by strong denaturizing agents into four polypeptides and RNA. The best analytical method to separate and characterize these polypeptides is the two-dimensional gel electrophoresis. Isoelectric focusing in urea sucrose gradients gives excellent separations also on a preparative scale. The antigenicity of poliovirus particles is the consequence of a complex cleavage pathway leading from the originally translated polyprotein to virus particles. Bearing in mind the need for a special conformation of the virus protein for N-antigenicity, ways are discussed of how to produce a non-infectious poliovirus vaccine in the future.
脊髓灰质炎病毒疫苗未来发展的分子基础是对病毒粒子结构的详细了解。在病毒制剂中可检测到不同类型和形式的脊髓灰质炎病毒颗粒。物理和化学性质比其电子显微镜图像更能表征病毒粒子。紧密的脊髓灰质炎病毒颗粒仅在强变性剂作用下才会解离成四种多肽和RNA。分离和表征这些多肽的最佳分析方法是二维凝胶电泳。在尿素蔗糖梯度中进行等电聚焦在制备规模上也能实现出色的分离。脊髓灰质炎病毒颗粒的抗原性是从最初翻译的多蛋白到病毒颗粒的复杂裂解途径的结果。考虑到病毒蛋白具有N抗原性需要特殊构象,讨论了未来生产非感染性脊髓灰质炎病毒疫苗的方法。